research use only
Cat.No.S3015
| Related Targets | Integrase Antibiotics Anti-infection Fungal Antiviral COVID-19 Parasite Reverse Transcriptase HIV HCV Protease |
|---|---|
| Other Bacterial Inhibitors | BTZ043 Racemate Teicoplanin Pefloxacin Mesylate Ceftiofur Solithromycin 6-Methoxydihydrosanguinarine Proanthocyanidins Flagelin 22 Taurolidine Skatole |
|
In vitro |
DMSO
: 73 mg/mL
(199.78 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 365.4 | Formula | C16H19N3O5S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 26787-78-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Amoxycillin | SMILES | CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C | ||
Read more about storage stability stock solution CAS number SMILES
| In vitro |
Amoxicillin treated cells secrete high amounts of interleukin-5 and mostly lower or no amounts of tumor necrosis factor alpha, interleukin-4, and interferon-gamma. This compound-specific T cell clones fails to show drug-specific cytotoxicity, but killed target cells in the presence of concanavalin A, indicating a principal ability to be cytolytic. It releases faster in pH 1.0 hydrochloric acid (HCl) than in pH 7.8 phosphate buffer. The chemical would be degraded to some extent in a pH 1.0 HCl medium at 37 degrees C, which indicated that it is not stable in an acidic surrounding. It inhibits 4 of 15 isolates at 8 mg/mL or less but is not bactericidal against any of the isolates at that concentration. This compound in combination with clavulanic acid is bactericidal for 14 of 15 isolates tested at an amoxicillin concentration of 4 mg/mL or less and a clavulanic acid concentration of 2 mg/mL or less. It inhibits 50% of isolates tested decreased from 0.5 mg/mL (range, 0.25 to 1 mg/mL) to 0.06 mg/mL (range, 0.01 to 0.25 mg/mL) in the presence of only 4 mg of cefotaxime per mL.
|
References |
|
|---|
(data from https://clinicaltrials.gov, updated on 2025-06-13)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06461429 | NOT_YET_RECRUITING | Preterm Birth |
University of Melbourne |
2025-11-01 | |
| NCT07730814 | NOT_YET_RECRUITING | Acute Otitis Media (AOM) |
Nader Shaikh |
2026-10-01 | PHASE4 |
| NCT07732699 | NOT_YET_RECRUITING | ACUTE SINUSITIS; Sinusitis |
Nader Shaikh |
2026-10-01 | PHASE4 |
| NCT07457385 | NOT_YET_RECRUITING | Syphilis, Congenital |
University of Alabama at Birmingham |
2026-11-01 | PHASE4 |
| NCT07485010 | NOT_YET_RECRUITING | Mycobacterium Abscessus Pulmonary Disease; Mycobacterium Abscessus Infection; Non-Tuberculous Mycobacterial (NTM) Infections; Non-Tuberculous Mycobacteria Pulmonary Disease |
The University of Queensland |
2027-04 | PHASE2 |
| NCT07576959 | RECRUITING | HELICOBACTER PYLORI INFECTIONS |
National Taiwan University Hospital |
2026-04-08 | PHASE3 |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.